Latest news
Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment - TradingViewTradingView · Fri, 07 Aug 2026 11:49:41 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - BenzingaBenzinga · Thu, 06 Aug 2026 05:32:01 GMTWhy Is Moderna Stock Gaining Wednesday? - Moderna (NASDAQ:MRNA) - BenzingaBenzinga · Wed, 05 Aug 2026 09:47:48 GMTFDA Approval Nearly Doubles Eligible Patient Pool For Novartis' Pluvicto - BenzingaBenzinga · Mon, 03 Aug 2026 16:56:48 GMTRocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial - BenzingaBenzinga · Mon, 03 Aug 2026 16:03:07 GMTReplimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote - BenzingaBenzinga · Fri, 31 Jul 2026 14:09:17 GMTNovo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients - BenzingaBenzinga · Fri, 31 Jul 2026 13:32:27 GMTKaryopharm Stock (KPTI) Crashes After Hours: Here's What's Driving the Move - BenzingaBenzinga · Fri, 31 Jul 2026 07:00:00 GMT